Clinical Trials Logo

Renal Insufficiency clinical trials

View clinical trials related to Renal Insufficiency.

Filter by:

NCT ID: NCT03397550 Withdrawn - Clinical trials for Chronic Kidney Diseases

The Relationship Between Salt Restriction and Taste Sensitivity in Patients With Chronic Kidney Disease

Start date: June 18, 2022
Phase:
Study type: Observational

The compliance of salt restriction in patients with CKD may be associated with taste sensitivity.

NCT ID: NCT03329612 Withdrawn - Clinical trials for Acute Coronary Syndrome

Remote Ischemic Preconditioning in ACS Patients

Start date: October 26, 2016
Phase: N/A
Study type: Interventional

Remote ischemic preconditioning is a process of serial blood pressure cuff inflations and deflations that are performed prior to a procedure and have been shown in various other areas (coronary bypass surgery, vascular surgery, ST elevation myocardial infarctions) to decrease the rates of adverse events related to ischemic burden and renal injury. This procedure has not yet been studied in the population presenting with an acute coronary syndrome (ACS), even though ACS patients represent the majority of patients seen in the catheterization lab. The purpose of this study is to evaluate the efficacy of this simple and safe procedure in this particular population.

NCT ID: NCT03093740 Withdrawn - Hepatitis C Clinical Trials

Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant

Start date: October 1, 2018
Phase: Phase 4
Study type: Interventional

Open label single center study for the donation of HCV positive kidneys to HCV negative recipients with interventional treatment to prevent HCV transmission upon transplantation.

NCT ID: NCT03043144 Withdrawn - Malnutrition Clinical Trials

Taste And Smell TEsting in End Stage Renal Disease

TASTE ESRD
Start date: February 15, 2017
Phase: N/A
Study type: Observational

Malnutrition is an important complication of advanced kidney disease and impairment in smell and taste may affect nutritional status. This study will examine the association between impairment in smell and taste and nutritional and functional markers among patients with end stage renal disease, as well as risk factors for smell and taste impairment.

NCT ID: NCT03036826 Withdrawn - Clinical trials for Acute Kidney Insufficiency

Computer-based Dosage Calculation for Antibiotics

Start date: June 2019
Phase:
Study type: Observational

Adequate dosing of antiinfective therapy in critically ill patients with impaired or lost renal function or continuous renal replacement therapy is nearly impossible without measuring the drug concentration in blood samples. In many hospitals that is still not an option. The investigators aim to show, that computer based calculation can avoid over- or under-dosing.

NCT ID: NCT03019159 Withdrawn - Clinical trials for Chronic Renal Failure

Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis

HSMDP
Start date: September 2014
Phase: N/A
Study type: Observational

The objective of the study is to determine whether tele-consulting for the follow up of patients with renal failure under peritoneal dialysis would not increase the risk of experiencing a severe adverse event

NCT ID: NCT02848508 Withdrawn - Clinical trials for Renal Insufficiency, Chronic

Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study

METsuiviIRC
Start date: March 16, 2016
Phase: Phase 2
Study type: Interventional

To validate on the mid-term in moderate and severe renal failure (CKD 3-4) a nomogram to adapt a fixed metformin daily posology according to renal function on the basis of the first short-term study made by the investigators.

NCT ID: NCT02568514 Withdrawn - Diabetes Clinical Trials

Study of the Effect on Clinical Outcomes Using Secure Text Messaging

Start date: August 2016
Phase: N/A
Study type: Interventional

In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

NCT ID: NCT02397395 Withdrawn - Clinical trials for End-stage Renal Disease

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Start date: May 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the percentage of participants with sustained virologic response 12 weeks after the actual end of study treatment (SVR12)

NCT ID: NCT02368249 Withdrawn - Kidney Failure Clinical Trials

Does Terlipressin Improve Renal Outcome After Liver Surgery

TIROL
Start date: January 2020
Phase: Phase 2
Study type: Interventional

The investigators aim to address whether terlipressin improves the renal outcome after liver surgery. Therefore the investigators are planning to conduct a double-blinded randomized control trial. The investigators will randomize patients undergoing any kind of liver surgery and being at increased moderate to high risk for post-operative acute renal failure into a control group receiving post- operative a placebo or into a group receiving post-operatively terlipressin in combination with human albumin.